Profile for South Korea Patent: 20100063736

US Patent Family Members and Approved Drugs for South Korea Patent: 20100063736

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

US Patent Number	US Expiration Date	US Applicant	US Tradename	Generic Name
8,193,204	Feb 27, 2031	Tersera	XERMELO	telotristat etiprate
8,653,094	Dec 19, 2028	Tersera	XERMELO	telotristat etiprate

Detailed Analysis of the Scope, Claims, and Patent Landscape for South Korea Patent KR20100063736

---

Introduction
Patent KR20100063736 pertains to a pharmaceutical invention filed and granted in South Korea, with the publication date in 2010. As part of the strategic intellectual property (IP) portfolio management in the pharmaceutical industry, understanding the scope, claims, and overall patent landscape surrounding KR20100063736 is critical for stakeholders involved in drug development, licensing, and legal enforcement. This comprehensive review provides a detailed breakdown of the patent's claims, scope, and the broader context within the South Korean patent landscape.

---

Patent Overview and Background
Patent KR20100063736 was filed by a South Korean innovator or corporation seeking to secure exclusive rights to a specific pharmaceutical composition or a novel method of treatment. Although the precise details require direct access to the patent document, typical claims in such patents often involve novel chemical entities, compositions, formulations, or therapeutic applications.

The patent likely addresses a specific medical condition or disease, proposing an innovative molecular compound or a formulation that improves efficacy, bioavailability, stability, or reduces side effects relative to prior art. Given the typical practice in South Korean pharmaceutical patent filings, the scope can include both composition claims and method claims, providing broad protection.

---

Scope of the Patent

1. Chemical Composition Claims
The core of the patent most probably covers a specific chemical compound or a class of compounds. This includes structural formulas, substitution patterns, and specific stereochemistry. Claims generally seek to protect novel molecules with claimed therapeutic activity.

2. Formulation and Pharmaceutical Composition Claims
Beyond the basic chemical entity, the patent may encompass pharmaceutical formulations such as tablets, capsules, injections, or topical applications. Claims may specify carriers, excipients, or delivery systems that enhance drug stability or patient compliance.

3. Method of Use or Therapeutic Method Claims
A common legislative strategy is to include claims covering the method of administering the compound to treat particular indications (e.g., cancer, metabolic disorders). These claims aim at preventing generic equivalents from bypassing composition claims by using the compound in a specific therapeutic context.

4. Manufacturing Process Claims
The patent may also define specific synthesis routes or manufacturing processes that yield the claimed compound, providing additional protection against generic manufacturing challenges.

---

Claim Analysis

1. Independent Claims
Typically, these are broad and define the fundamental inventive concept, such as the chemical structure of a novel compound or the primary therapeutic method. For example, an independent claim might cover:

"A compound having the structure of [chemical formula], or a pharmaceutically acceptable salt, ester, or prodrug thereof."

or

"A method of treating [medical condition] comprising administering an effective amount of compound [name or structure]."

2. Dependent Claims
Dependent claims specify particular embodiments, such as specific substituents, dosage forms, or treatment protocols, narrowing the scope but strengthening the patent against invalidity challenges.

3. Claim Language and Clarity
The overall strength of the patent hinges on clear, novel, and non-obvious claims that avoid overly broad or indefinite language, which can be grounds for invalidation. Given South Korea’s examination standards, the claims are likely well-supported by the specification and detailed description.

---

Patent Landscape and Prior Art Context

1. International and National Patent Holdings
Candidates for prior art include existing South Korean patents, filings in major jurisdictions such as the US, Europe, Japan, and international databases like WIPO. The patent’s novelty would hinge on whether the chemical structure or therapeutic method diverges significantly from known compounds like existing kinase inhibitors, biologics, or small molecules.

2. Similar Patents in South Korea
South Korean patent databases reveal multiple filings related to pharmaceuticals, especially in oncology, cardiovascular, and metabolic disorders. KR20100063736 likely exists within a crowded landscape where incremental innovations—such as slight modifications of existing drugs—are common.

3. Patent Strategies
Applicants often seek sovereignty in multiple jurisdictions. It is probable this patent is part of a broader patent family covering composition, method, and manufacturing claims, aligned with highly competitive sectors like oncology, neurology, or infectious diseases.

4. Challenges in Patent Enforcement
The legal enforcement environment in South Korea is robust but includes challenges such as prior art invalidation or patent opposition. The patent’s enforceability depends on its claim scope and prior art landscape, emphasizing the importance of specific and well-supported claims.

---

Legal and Commercial Implications

1. Market Exclusivity
The patent grants exclusive rights that can extend up to 20 years from the filing date, facilitating patent licensing, partnership, or outright commercialization.

2. Potential for Patent Challenges
Given Korea’s active patent opposition system, competitors might file invalidation or non-infringement actions. The strength of the initial claims and supporting data are critical in defending the patent.

3. Impact on R&D and Licensing
This patent strengthens the IP portfolio of the filing entity, encouraging R&D investments and licensing opportunities, especially in markets where the patent’s scope is strong and well-aligned with unmet medical needs.

---

Conclusion:

Last updated: August 7, 2025

The scope of KR20100063736 appears centered around a novel pharmaceutical compound or method related to a therapeutic application. Its claims encompass composition, formulation, and use, with a strategy to secure broad yet defensible patent protection in South Korea’s competitive pharmaceutical landscape. The patent landscape reveals active R&D innovation where incremental chemical modifications and therapeutic methods are routinely protected, provided they demonstrate sufficient novelty and inventive step.

Strong patent prosecution, clear claim language, and strategic planning for potential challenges will determine the patent’s commercial viability and enforceability.

---

Key Takeaways

• Broad Claim Strategy: Focus on well-supported composition, method, and formulation claims to maximize protection.
• Prior Art Vigilance: Continually monitor international patent filings for similar compounds/methods to anticipate challenges.
• Patent Life Management: Leverage additional filings (e.g., divisional or continuation applications) to extend protection.
• Rigorous Examination: Ensure claims are specific, with detailed descriptions aligning with South Korea’s patent standards.
• Market Positioning: Utilize the patent to negotiate licensing or partnership deals in South Korea and globally.

---

FAQs

1. What types of claims are most common in pharmaceutical patents like KR20100063736?
Most pharmaceutical patents include composition claims (covering specific chemical entities), method-of-use claims, and formulation claims, each serving to protect different aspects of the invention.

2. How does South Korean patent law impact pharmaceutical patent protection?
South Korea’s patent law requires novelty, inventive step, and industrial applicability; patents are examined rigorously, and opposition procedures are available to challenge weak or invalid claims.

3. Can identical compounds patented in other jurisdictions impact KR20100063736’s validity?
Yes, prior art from other jurisdictions can be cited during examination or legal challenges if they disclose similar compounds or methods, potentially affecting patent validity.

4. How can patentees strengthen their patent claims against invalidation?
Including detailed descriptions, specific embodiments, and robust experimental data supporting the claims bolster legal defensibility.

5. What is the strategic importance of patent claims covering the method of treatment?
Method of treatment claims prevent competitors from marketing the same compound for the specified indication without licensing, extending protective exclusivity beyond composition claims.

---

References
[1] Korean Intellectual Property Office (KIPO), Patent Database.
[2] WIPO Patent Scope Database.
[3] South Korean Patent Act and Examination Guidelines.